Literature DB >> 3928973

Estradiol entry into endometrial cells in suspension.

L M De Ryck, J B Ross, P H Petra, E Gurpide.   

Abstract

Cells from a human endometrial adenocarcinoma cell line (HEC-50) were superfused with mixtures of [3H]E2 and [14C]E1 in order to estimate rates of entry and exit of E1 and E2 into and out of cells according to previously published procedures (J. steroid Biochem., 13 (1980) 1379). Proportionality between rates of entry and concentrations of E2 outside the cells, indicative of passive diffusion, was found at levels of E2 ranging from 1 to 100 ng/ml. Effects of albumin and of pure human sex steroid binding protein (SBP) on the rate of entry of E2 were also evaluated in parallel superfusions. In other single tracer experiments, [3H]E2 was used at concentrations as low as 100 pg/ml and the effects of plasma proteins on entry were evaluated by measuring steady-state concentrations of E2 and E1 in cells and superfusate. Results from these experiments indicate that albumin, and to a larger extent SBP, reduced the entry of E2 into HEC-50 cells. Similar results were obtained when CG-5 cells, a variant of the human breast cancer cell line MCF-7, were superfused with [3H]E2. Further experiments are needed, however, to determine the physiologic role of plasma estrogen binding proteins on the entry and metabolism of E1 and E2 into target cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3928973     DOI: 10.1016/0022-4731(85)90229-8

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  3 in total

Review 1.  Hirsutism: pilosebaceous unit dysregulation. Role of peripheral and glandular factors.

Authors:  V Toscano
Journal:  J Endocrinol Invest       Date:  1991-02       Impact factor: 4.256

2.  Nonlinear binding of sex steroids to albumin and sex hormone binding globulin.

Authors:  T Zeginiadou; S Kolias; D Kouretas; O Antonoglou
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jul-Sep       Impact factor: 2.441

3.  Investigation of female survival benefit in metastatic melanoma.

Authors:  B Richardson; A Price; M Wagner; V Williams; P Lorigan; S Browne; J G Miller; S Mac Neil
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.